Bound Brook, NJ (PRWEB) August 11, 2014
DZS Software Solutions (DZS), a provider of the ClinPlus® software products and services supporting several aspects of clinical trials, today announced the official release of ClinPlus® CTMS 2.2. This release builds on a reliable and robust system that has gained enormous popularity primarily for its combination of features, usability and cost-effectiveness.
Some of the most significant enhancements include:
In addition, many new reporting features and metrics were added for better insight, calendar features were enhanced, and new custom table definition tools were added to capture “non-standard” or study specific information. “Version 2.2 contains many enhancements, nearly all of which are a direct result of customer requests,” said Steve Trigilio, ClinPlus CTMS Program Manager. “The most challenging aspect of developing such a powerful, flexible system with so many features and options is to maintain a user experience that is familiar and convenient, in short, making a complex system comparatively simple. We believe we have accomplished this in Version 2.2 and the initial reaction from our clients is our confirmation.”
ClinPlus® CTMS Version 2.2 is available now, for more information or to schedule a live demonstration, please contact Bob Borysko, VP of Business Development, (732) 764-6969 Ext: 128 or visit http://www.clinplus.com/products/CTMS/.
About DZS Software Solutions, Inc.
DZS Software Solutions, Inc. is a privately held company founded in 1984 providing clinical trials software for clinical data management and analysis to the biotech and pharmaceutical industry worldwide. Over 60 clients globally presently use ClinPlus® software for data collection and capture, data cleansing, coding, analysis, clinical trial management and reporting. When the software is coupled with DZS services and training, many ClinPlus® clients have dramatically improved productivity and maximized the value of clinical research investments and gained a competitive advantage to get medicines and products to market faster.